APA

Logan A. C., Zhang B., Narasimhan B., Carlton V., Zheng J., Moorhead M., Krampf M. R., Jones C. D., Waqar A. N., Faham M., Zehnder J. L. & Miklos D. B. (20131021). Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia. : Leukemia.

Chicago

Logan A C, Zhang B, Narasimhan B, Carlton V, Zheng J, Moorhead M, Krampf M R, Jones C D, Waqar A N, Faham M, Zehnder J L and Miklos D B. 20131021. Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia. : Leukemia.

Harvard

Logan A. C., Zhang B., Narasimhan B., Carlton V., Zheng J., Moorhead M., Krampf M. R., Jones C. D., Waqar A. N., Faham M., Zehnder J. L. and Miklos D. B. (20131021). Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia. : Leukemia.

MLA

Logan A C, Zhang B, Narasimhan B, Carlton V, Zheng J, Moorhead M, Krampf M R, Jones C D, Waqar A N, Faham M, Zehnder J L and Miklos D B. Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia. : Leukemia. 20131021.